Detalhe da pesquisa
1.
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Cell
; 173(3): 611-623.e17, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656891
2.
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Cell
; 173(3): 595-610.e11, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656894
3.
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Cell
; 173(3): 581-594.e12, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656895
4.
Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI.
Eur Radiol
; 27(2): 627-636, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221560
5.
Preoperative imaging in patients undergoing trachelectomy for cervical cancer: validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T.
Gynecol Oncol
; 133(2): 326-32, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582988
6.
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.
Nat Ecol Evol
; 6(1): 88-102, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34949820
7.
Selection of metastasis competent subclones in the tumour interior.
Nat Ecol Evol
; 5(7): 1033-1045, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002049
8.
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
; 39(11): 1497-1518.e11, 2021 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34715028
9.
Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial origin.
Histopathology
; 66(6): 898-901, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041380
10.
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial.
Int J Radiat Oncol Biol Phys
; 106(4): 715-724, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812718
11.
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.
ESMO Open
; 2(1): e000101, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761723
12.
Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.
J Clin Pathol
; 68(9): 703-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041862
13.
Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.
Anticancer Res
; 35(12): 6713-22, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637887
14.
Rhabdomyosarcoma with pseudolipoblasts arising in ovarian carcinosarcoma: a distinctive postchemotherapy morphologic variant mimicking pleomorphic liposarcoma.
Case Rep Pathol
; 2014: 238545, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24587930
15.
Melanoma with rhabdomyosarcomatous differentiation: two further cases of a rare pathologic pitfall.
Int J Surg Pathol
; 22(6): 512-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788528
16.
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.
Genome Biol
; 15(8): 433, 2014 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25159823
17.
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
Clin Cancer Res
; 17(24): 7673-83, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22038995